Literature DB >> 10920727

Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.

L Pilote1, F Lavoie, V Ho, M J Eisenberg.   

Abstract

BACKGROUND: Few studies have reported population-based information on the treatment trends and outcomes of patients who have had an acute myocardial infarction (AMI). We therefore examined patterns of care and outcomes for AMI patients in Quebec, Canada, between 1988 and 1995.
METHODS: Longitudinal data files of hospital admissions in Quebec (Med-Echo database) and inpatient and outpatient services (Régie de l'Assurance Maladie du Québec database) were used to construct cohorts of all AMI patients in the province between 1988 and 1995. Temporal trends in the use of cardiac procedures after an AMI, discharge prescriptions and mortality rates were examined.
RESULTS: Between 1988 and 1995 the age- and sex-adjusted rates of AMI in the Quebec population declined (148 per 100,000 in 1988 to 137 per 100,000 in 1995). The use of intensive cardiac procedures increased in the same period; the 1-year cumulative incidence rate of catheterization increased from 28% in 1988 to 31% in 1994, that of angioplasty rose from 8% to 15% and that of coronary artery bypass surgery from 6% to 8%. Prescriptions for ASA, beta-blockers, lipid-lowering agents and angiotensin-converting enzyme inhibitors increased, and prescriptions for nitrates and calcium antagonists decreased. These temporal changes were paralleled by a decrease in mortality rates post-AMI. All-cause 1-year cumulative incidence mortality rates decreased from 23% in 1988 to 19% in 1994.
INTERPRETATION: The decrease in AMI-related mortality in Quebec between 1988 and 1995 may be linked to changes in treatment strategies (i.e., increased use of cardiac surgical procedures and medications shown to increase survival).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920727      PMCID: PMC1232547     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  17 in total

1.  Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.

Authors:  G A Lamas; M A Pfeffer; P Hamm; J Wertheimer; J L Rouleau; E Braunwald
Journal:  N Engl J Med       Date:  1992-07-23       Impact factor: 91.245

2.  Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996.

Authors:  J V Tu; C D Naylor; P Austin
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

3.  Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.

Authors:  D B Mark; C D Naylor; M A Hlatky; R M Califf; E J Topol; C B Granger; J D Knight; C L Nelson; K L Lee; N E Clapp-Channing
Journal:  N Engl J Med       Date:  1994-10-27       Impact factor: 91.245

4.  Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals.

Authors:  L Pilote; N Racine; M A Hlatky
Journal:  Arch Intern Med       Date:  1994-05-23

5.  Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial.

Authors:  L Pilote; C Granger; P W Armstrong; D B Mark; M A Hlatky
Journal:  Med Care       Date:  1995-06       Impact factor: 2.983

6.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators.

Authors:  J L Rouleau; L A Moyé; M A Pfeffer; J M Arnold; V Bernstein; T E Cuddy; G R Dagenais; E M Geltman; S Goldman; D Gordon
Journal:  N Engl J Med       Date:  1993-03-18       Impact factor: 91.245

7.  Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.

Authors:  S Viskin; I Kitzis; E Lev; Z Zak; K Heller; Y Villa; A Zajarias; S Laniado; B Belhassen
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

8.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  L Pilote; R M Califf; S Sapp; D P Miller; D B Mark; W D Weaver; J M Gore; P W Armstrong; E M Ohman; E J Topol
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245

9.  Variation in the use of cardiac procedures after acute myocardial infarction.

Authors:  E Guadagnoli; P J Hauptman; J Z Ayanian; C L Pashos; B J McNeil; P D Cleary
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245

10.  Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  F Van de Werf; E J Topol; K L Lee; L H Woodlief; C B Granger; P W Armstrong; G I Barbash; J R Hampton; A Guerci; R J Simes
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

View more
  20 in total

1.  Treating acute myocardial infarction.

Authors:  D Kollek
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Treating acute myocardial infarction.

Authors:  W D Panton
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

3.  Acute myocardial infarction in Canada: improvement with time.

Authors:  A Dodek
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

4.  Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001.

Authors:  Najwa Ouhoummane; Belkacem Abdous; Rabia Louchini; Louis Rochette; Paul Poirier
Journal:  Can J Cardiol       Date:  2010-12       Impact factor: 5.223

5.  Temporal trends in revascularization and outcomes after acute myocardial infarction among the very elderly.

Authors:  Maude Pagé; Michel Doucet; Mark J Eisenberg; Hassan Behlouli; Louise Pilote
Journal:  CMAJ       Date:  2010-08-03       Impact factor: 8.262

6.  Changing trends in mortality and admissions to hospital for elderly patients with congestive heart failure in Montreal.

Authors:  D E Feldman; C Thivierge; L Guérard; V Déry; C Kapetanakis; G Lavoie; E J Beck
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

7.  Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004.

Authors:  Andrea V Margulis; Niteesh K Choudhry; Colin R Dormuth; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-04-28       Impact factor: 2.890

8.  Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease.

Authors:  Marie-Christyne Cyr; Marie-France Beauchesne; Catherine Lemière; Lucie Blais
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

9.  Validation of a decision model for preventive pharmacological strategies in postmenopausal women.

Authors:  Sylvie Perreault; Carey Levinton; Claudine Laurier; Yola Moride; Louis-Georges Ste-Marie; Ralph Crott
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

10.  Does aggressive care following acute myocardial infarction reduce mortality? Analysis with instrumental variables to compare effectiveness in Canadian and United States patient populations.

Authors:  Christine A Beck; John Penrod; Theresa W Gyorkos; Stan Shapiro; Louise Pilote
Journal:  Health Serv Res       Date:  2003-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.